91制片厂

Ochre News

NEWS COVERAGE

Meet the man trying to eradicate the need for liver transplants

91制片厂 the liver is the body鈥檚 most misunderstood organ

How old is YOUR liver? Take our 6-step test to find out if you’re at risk of fibrosis and cirrhosis鈥� and the easy lifestyle tweaks to de-age the organ FAST

All the economic wins Keir Starmer wants to bag in China

91制片厂 and GSK complete early research into human liver聽

Derisking clinical trials requires a 鈥榟uman first鈥� approach

Can the UK reclaim its status as a life sciences leader?

This company aims to end the need for liver transplants 鈥� as thousands die every year on the waitlist

16 UK startups (not from London) to watch, according to investors

Dr. Quin Wills at SXSW London 2025: Can AI Turn Animal Testing Human

25 European Startups to watch

The superpowers of weight-loss jabs extend to our livers

AI deals show no sign of slowing

91制片厂 appoints ex- Eli Lilly and AstraZeneca VP as Non-Executive Director

The Pharma Letter Podcast 鈥� Episode 33 鈥� 91制片厂 Boehringer and GSK are betting on Ochre

91制片厂, addressing the complexities of liver disease

Podcast: 91制片厂鈥檚 Approach To Precision Medicine In Liver Treatment

Changing the Odds in Liver Disease with Computational Biology and Human-first Models

Top 10 Spatial Biology Companies of 2024

BBC Click

Leading innovation: 10 promising European startups focusing on biopharmaceuticals

How to make your organs last longer | Quin Wills | TEDxNoVA

Drug discovery: 20 startups to watch

GSK signs AI pact with Ochre to pinpoint source of liver diseases

The Biotech Startups Podcast: Quin Wills

91制片厂 announces partnership with Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver disease

Boehringer signs $1.3B deal with RNA biotech 91制片厂 to team up against MASH

Boehringer Ingelheim inks chronic liver disease research pact with 91制片厂

UK biotech signs $1bn deal to develop liver disease drugs

Podcast: Unlock the potential of complex human liver data

UK startups are built on immigrant talent, the UK will fail if it forgets this

Future of liver drugs 鈥� better AI or better data?

91制片厂: fully human, super speedy liver drug development

Exploring liver disease therapies聽

91制片厂 with CEO/Co-founder Jack O’Meara and liver expert Dr Scott Friedman, Mount Sinai

Revolutionising Liver Transplants: Can Phenotyping Drive Biotech Transformation in Healthcare?

Business of Biotech with 91制片厂’s Quin Wills, M.D., PH.D

91制片厂 CEO named on Forbes 30 Under 30 Europe

18 European techbio startups to watch 鈥� according to investors

The intersection between healthcare, technology, strategy and impact 鈥� Interview with 91制片厂鈥檚 CEO and co-founder Jack O鈥橫eara

AI and computational biology transforming chronic liver disease research聽

鈥業 wanted to do something in health but I didn鈥檛 want to be a doctor鈥�: 91制片厂 founder Jack O鈥橫eara

91制片厂 Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors

Five Spatial Genomics Up-and-Coming Firms

Jeremy Hunt鈥檚 R&D shake-up divides UK small businesses

Oxford biotech raises funds to make RNA treatments for liver disease

RNA therapies startup 91制片厂 lands $30M to take on chronic liver disease

A liver disease upstart with some global connections and a new R&D strategy reaps a $30M launch round

Skydivers raise almost 拢10,000 for children at Helen & Douglas House

A New Era in European Life Sciences Investment

Chirps, chats and Clubhouses: First-time biotech founders turn to social media for advice, investors and recruitment

‘Day job and a gay job’: LGBTQ+ leaders in biopharma want those who look, talk and love like them to be seen and counted

Biotech Startup 91制片厂 Lands Seed Financing to Combat Liver Diseases

Biotech looks to upset the preclinical model for liver drug development, and now it’s gearing up for the clinic

Lyfebulb and CSL Behring Announce the Finalists for the 2021 Transplant Innovation Challenge

New hope for beating the hidden fatty liver epidemic, a silent killer

Entrepreneur First鈥檚 Latest European Cohort Revealed, With Plenty Of Biotech Startups On Show

All the companies from Y Combinator鈥檚 W20 Demo Day, Part IV: Healthcare, Biotech, Fintech and Nonprofits

Join our Mailing List